These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 92366)

  • 1. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 2. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B; Jones TC; Roitt IM
    Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 4. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 5. Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.
    Bonavida B
    J Exp Med; 1977 Feb; 145(2):293-301. PubMed ID: 299880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low numbers of tumor cells suppress the host immune system.
    Kölsch E; Mengersen R
    Adv Exp Med Biol; 1976; 66():431-6. PubMed ID: 817574
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bacille Calmette-Guérin on the immune response of BALB/c mice to a tumor allograft.
    Treagan L; Chen TH; Rambo O; Elberg SS
    J Infect Dis; 1979 Oct; 140(4):541-5. PubMed ID: 117062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphomas with cytotoxic activity.
    Chang TW; Eisen HN
    Nature; 1979 Aug; 280(5721):406-8. PubMed ID: 313526
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-adaptive rejection of small tumour inocula as a model of immune surveillance.
    Greenberg AH; Greene M
    Nature; 1976 Nov; 264(5584):356-9. PubMed ID: 826828
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment of P815 mastocytoma cells with inhibitors of protein synthesis reduces their susceptibility to lysis by cytotoxic thymus-derived lymphocytes.
    D'Angeac AD; Hale AH
    Cell Immunol; 1980 Oct; 55(2):342-54. PubMed ID: 6775821
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated cytotoxicity in humans: age-related decline as measured by a xenogeneic assay.
    Becker MJ; Farkas R; Schneider M; Drucker I; Klajman A
    Clin Immunol Immunopathol; 1979 Oct; 14(2):204-10. PubMed ID: 114349
    [No Abstract]   [Full Text] [Related]  

  • 18. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated cytotoxicity against syngeneic tumors.
    Sinclair NR; McFarlane DL; Low JM
    Cell Immunol; 1981 Apr; 59(2):330-44. PubMed ID: 6793241
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of cytotoxic T-cell function by virus.
    Reinisch CL; Schlossman SF
    J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.